Archive · 2 Oct 2025
European Doctors: Weight-loss drugs are the first option.
Imagine some medicines are like super helpers for people who are too heavy.
Doctors in Europe are saying these super helpers should be the first thing people try to get healthier.
These medicines, like Wegovy and Zepbound, can help people lose a lot of weight.
They are especially good for people who have health problems because of their weight.
The doctors believe these medicines are so good that they should be the first choice for most people who need to lose weight.
Other, less powerful helpers could be used if less weight loss is needed.
The goal is to treat obesity and all its problems.
European doctors recommend weight-loss drugs as the primary treatment for obesity.
Semaglutide and tirzepatide are identified as the preferred options.
Guideline suggests using other medications if less weight loss is required.
The drugs can improve obesity-related complications.
The EASO will update the guideline regularly to incorporate new evidence.
- Who
- European Association for the Study of Obesity (EASO).
- What
- Recommends weight-loss drugs as first treatment option for obesity.
- When
- Guideline published Thursday.
- Where
- Europe.
- Why
- To address obesity and its complications more effectively.
- Key Drugs
- Semaglutide (Wegovy, Ozempic), Tirzepatide (Zepbound, Mounjaro)
- Medical Association
- European Association for the Study of Obesity (EASO)
- Recommendation
- First-line treatment for obesity and complications
- Guideline Type
- Non-binding
- Drug Class
- GLP-1 agonists